PI Industries to acquire API biz from Ind-Swift Labs indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Views: Visits 7 Pharmaceutical Society of Nigeria, PSN By Chioma Obinna President of the Pharmaceutical Society of Nigeria PSN, Pharm Sam Ohuabunwa weekend lauded the African Development Bank AfDB on its decision to invest 3 billion dollars ($3 billion) to build Africa’s pharmaceutical industry in the next 10 years as well as support the Africa Centre for Disease Control, Africa CDC, with 28 million dollars to strengthen its capacity to ensure the manufacture of vaccines in the continent. Ohuabunwa said PSN cannot agree more with the President, AfDB, Dr Akinwumi Adesina statement during a meeting themed ‘Africa’s Green and Resilient Recovery: A Common Objective’, in his submission. “Let’s finance in common and build a common positive story of innovation and investment in Africa, leveraging and mobilising all willing stakeholders. The days of pure aid are over. Africa is ready for sustainable investment.”
On a consolidated basis, Divi s Laboratories reported 31.1% jump in net profit to Rs 470.62 crore on a 21.9% rise in net sales to Rs 1701.44 crore in Q3 FY21 over Q3 FY20.
The company reported a forex gain of Rs 2.53 crore in the quarter ended December 2020 as against a forex gain of Rs 17.96 crore in the quarter ended December 2019.
Profit before tax in Q3 December 2020 stood at Rs 642.08 crore, up by 31.8% from Rs 487.32 crore in Q3 December 2019. Current tax expenses during the quarter increased by 18.4% year-on-year (YoY) to Rs 144.78 crore. The company has been able to have normalized operations during the quarter, Divi s Lab said in a statement.